Review on Properties of Nanoparticles, Characteristics and Health Perspectives

INTRODUCTION

Within that description a nano-object only requires one of its characteristic measurements to be categorised as a nanoparticle inside the range 1–100 nm, even though the other measurements are below that range. (The lower limit of 1 nm is chosen since the duration of the atomic connexion is 0.1 nm.) The size range — from 1 to 100 nm — significantly overlaps with that historically applied to the area of colloid science — from 1 to 1000 nm — that is often considered the mesoscale. But seeing literature relating to nanoparticles & colloidal particles in similar words is not rare. The distinction between particles smaller than 100 nm in size is basically qualitative. organic & inorganic NP; the first category includes dendrimers, liposomes, & polymeric NP, while the second group includes fullerenes, quantum dots, & gold nanoparticles. Other classifications distinguish nanoparticles, depending on if they are carbon, clay, semiconducting or polymeric. Nanoparticles can also be categorised as hard (e.g., titanium [titanium dioxide], silica [silica dioxide] particles, & fullerenes) or fragile (e.g., liposomes, vesicles, & nanodroplets). The way nanoparticles are usually categorised varies on their use, for example in medicine or treatment versus basic science, or may be linked to how they were made. There are three main physical properties of NP, that are all interlinked: (1) they are extremely elastic in the free state ( e.g., in the absence of any external impact, a silica 10-nm-diameter nanosphere has a gravity sedimentation rate of 0.01 mm / day in water); (2) they have large unique surface areas ( e.g., a typical teaspoon, or around 6 ml, 10-nm-diameter size). Nanoparticles also provide a broad variety of formulations, depending on the use or the substance.

Overall, innovations focused on nanoparticles concentrate on ways to enhance the performance, durability & speed of already-existing systems. This is possible since, compared to the materials commonly utilized for industrial processes ( e.g., industrial catalysis), innovations focused on nanoparticles require fewer content, in which a significant proportion is now in a more "reactive" condition. Other prospects for technology focused on nanoparticles involve the usage of nanoscale zero-valent iron (NZVI) particles in the atmosphere as a field-deployable method of remediation of organochlorine substances, like polychlorinated biphenyls (PCBs). NZVI particles could permeate in ground rock layers & neutralise organochlorine reactivity in deep aquifers. Other uses of nanoparticles include those that benefit from shaping or assembling nanoscale matter to have improved coatings, composites or additives and others that harness the quantum effects of the particles (e.g., quantum dots for sensing, nanowires for molecular electronics, & spintronics & molecular magnet technologies).

Using such sophisticated microscopic techniques as scanning electron microscopy ( SEM), transmission electron microscopy (TEM) & atomic force microscopy ( AFM), nanoparticles are typically defined by their scale, shape , and surface charge. The average diameter of the particles, their size distribution and charge influence the physical stability & nanoparticles distribution in vivo. Techniques for electron microscopy are very helpful in evaluating the ultimate structure of polymeric nanoparticles that could assess their toxicity. The nanoparticles' surface charges influence the physical stability & redispersibility of the polymer dispersion & also there in vivo efficiency Particle size: The distribution & composition of particles are the most critical parameters in nanoparticles characterization. Electron microscopy is used to measure morphology & size. Nanoparticles has major role in drug release and drug selection. Particle size has shown to have an effect on drug production. Smaller particles have greater surface space. As a consequence, much of the medication loaded into them would be released to the surface of particles contributing to rapid release of the substance. On the opposite, there is a sluggish diffusion of medicines inside larger objects. As a downside smaller particles prefer to accumulate during nanoparticle dispersion preparation & transport. Therefore there is a balance between a limited scale & optimum nanoparticles stability (Redhead et al., 2001). Particular size could also influence the deterioration of polymers. The degradation rate of poly (lactic-co-glycolic acid), for example, shown to grow with the particle size in vitro (Betancor et al., 2000). As stated below, there are many methods for calculating the size of the nanoparticles Dynamic light scattering (DLS): Photon-correlation spectroscopy (PCS) or dynamic light scattering (DLS) is currently the quickest & most common form of calculating particle size. DLS is commonly utilized in nano- & submicron ranges for evaluating monochromatic light (laser) onto a solution of spherical particles induces a Doppler change as the light reaches the moving object, shifting the wavelength of the incoming light. This alteration is relevant to particle size. The size distribution could extracted & definition of the motion of the particle in the medium can be given, the diffusion coefficient of the particle is calculated & autocorrelation method is used. Photon correlation spectroscopy (PCS) is the most widely utilized technique for precise, DLS-based measurement of particle size & size distribution (DeAssis et al., 2008). Scanning Electron microscopy: SEM provides precise interpretation of the morphological analysis. Electron microscopy-based techniques offer many benefits in morphological & scaling analysis; however, they often provide limited information on size distribution & true population average. Nanoparticles solution ought be processed into a dry powder for SEM characterisation, that is then placed on a sample holder and then covered with a conductive metal, such as steel, utilizing a sputter coater. The nanoparticles should be able to endure vacuum, & could destroy the polymer by the electron beam. The mean size obtained by SEM is equivalent to the findings obtained by dispersing dynamic radiation. In addition, these approaches are time-consuming, expensive & also involve complementary sizing delivery details (Molpeceres et al., 2000). Transmission electron microscope: TEM works on a different system than SEM, but often carries in the same data type. TEM sample preparation is complex & time consuming due to its prerequisite to be ultra thin for transmitting electrons. The dispersion of the nanoparticles is accumulated on help grids or films. To avoid the instrument vacuum & allow handling, nanoparticles are fixed utilizing either a negative staining medium, like phosphotungstic acid or equivalents, uranyl acetate, respectively., or plastic embedding content. Alternate method is to reveal the sample to levels of liquid nitrogen after embedding it in vitreous material. Sample surface features are calculated by transmitting a beam of electrons across an ultra thin sample, engaging with the sample as it passes through (Molpeceres et al., 2000). Atomic force microscopy: Atomic force microscopy (AFM) achieves ultra-high precision of particle size estimation & based on submicron-level physical scanning of samples utilising an atomic-scale probe tip (Muhlen et al., 1996). Instrument produces a topographical field chart dependent on the powers between the tips & surface of the field. Generally, samples are screened in touch or non-contact mode based on their properties. In touch mode, the topographical map is created by tapping the probe onto the surface via the sample, & non-contact mode, the probe hovers over its conducting surface. AFM's primary benefit is its capacity to model non- microstructures to be imaged (Shi & Farber, 2003). AFM has the most precise scale and scale distribution definition, which does not need mathematical care. In addition, the particle size acquired by the AFM technique gives a real picture that helps to understand the effects of different biological conditions (Polakovic et al., 1999). Surface Charge: The nature & intensity of nanoparticles 'surface charge is very significant since it dictates their contact with the biological environment & their electrostatic interaction with bioactive compounds. The colloidal stability is studied by nanoparticles' zeta potential. This ability is an indirect indicator of the charge on the surface. It refers to possible difference between the shear surface & outer Helmholtz axis. Measuring the zeta potential enables for projections about the colloidal dispersion storage stability. To maintain equilibrium and prevent accumulation of the particles, high zeta potential values, whether positive or negative, must be obtained. You can then estimate the degree of surface hydrophobicity from the zeta potential values. The zeta potential may also include details about the type of substance that is encapsulated or covered on the surface of the nanocapsules (Pangi et al . 2003). Surface hydrophobicity: Surface hydrophobicity could be calculated by different techniques including chromatography of the hydrophobic interface, biphasic partitioning, sample adsorption, impact angle measurements, respectively. Several advanced analytical methods for the surface examination of nanoparticles have recently been published in literature. X – Spectroscopy of the ray photon interaction helps to classify unique chemical functional group of nanoparticles (Scholes et al., 1999). Drug Release: A key reason to explore nanotechnology is to transport drugs, hence it is necessary to understand how and to what degree the drug molecules are produced. To achieve such details certain methods of release involve isolation of the medication & its distribution mechanism. The nanoparticles' drug loading is commonly described as the quantity of drug bound by polymer mass (usually moles of drug per mg polymer or mg drug per mg polymer); then it could be offered as a percentage relative to the polymer. Quantification is achieved with the UV or HPLC spectroscopy. Drug release assays are often close to medication loading assays are tested over a period of time to test drug release processes. is essential. The formers pose a significant danger to health, as they are tougher to control due to airborne and could be inhaled. Nanoparticles may reach the human body in several ways I through the lungs so rapid translocation to vital organ via the bloodstream is feasible, such crossing the BBB & absorption (ii) thru the intestinal tract (iii) via the skin (Hoet et al., 2004). Lungs: Focused on three forms of titanium dioxide (TiO2) carbon black and diesel particles, hazard tests in rats indicate that lung administration of ultrafine nanoparticles causes more powerful adverse effects in the form of inflammation & resulting tumours relative to larger particles with the same chemical composition at equal mass concentration. Surface properties including surface chemistry may play a major role in the toxicity of nanoparticles (Lee et al., 1998). Intestinal Tract: The tiny & broad intestinal epithelium is in direct touch with ingested material to facilitate the use of nutrients. A mixture of produced disaccharides, peptides, fatty acids, & monoglycerides through digestion in the small intestine can be further converted & taken in the villi. Charged particles such as carboxylated polystyrene nano particles or those made of positively charged polymer demonstrate low oral bioavailability by means of electrostatic repulsions and imply trapping (Jani et al., 1989). The smaller the particle diameter the quicker they could infiltrate the mucus to enter the colonic eutrocytes;14 nm of diameter permeated within 2 minutes, 415 nm of particles look 30 minutes, whereas 1000 nm of particles do not translocate this barrier (Jani et al., 1990). Skin: Particles 500-1000 nm in size will potentially penetrate and enter the lower layers of human skin outside the limits of nano-technology, 128 & smaller particles more probably to infiltrate the skin (Lademann et al., 1989).

Swati Tyagi et. al. (2016) The aim of the researcher is to illustrate the evolving value of nanotechnology with a focus on nanoparticles with existing science research in the biomedical, medicinal, optical, biosensor, & electronic fields. A general description of the classification of nanoparticles like 1D , 2D & 3D structures of organic & inorganic molecules demonstrating a broad variety of uses in frequent fields of expertise in this paper. Nanotechnology that uses nanoparticles would related to any area of drugs, electricity, electronics, manufacturing & materials, food, textiles, climate, green energy, quantic devices, UV safety & industrial catalysts. possibilities and reach that are anticipated to have major applications in disease diagnostics & therapy. Nano-pharamceuticals recently expose immense promise in the distribution of medicines as a conduit for the spatial & temporal transmission of bioactive & diagnostic goods. It also offers intelligent materials for the tissue engineering. This specialty is now well known by its nanoengineered methods for the distribution of medications, diagnostics, prognosis and treatment of diseases. There are already several nanotech related devices and distribution mechanisms on the market. Pharmaceutical nanotechnology consisting of nano-sized materials that can be converted to enhance their properties in several respects. Drugs that are converted into nano range provide certain interesting features that could contribute to extended absorption, enhanced position of drugs, increased potency of drugs, respectively. Pharmaceutical nanotechnology may, with the assistance of nanopharmaceuticals, have a significant impact on disease prevention & have deeper visibility into the molecular basis of disease. But some health risk data recently uncovered restricts their usage in the pharmaceutical sector. Scientists address certain problems such as protection, bioethical concerns, contamination risks, physiological & medicinal challenges. Present researchers also lack adequate evidence and guidance on the safe usage of such devices & materials dependent on nanotechnology. The medicinal nanotechnology is therefore only in infancy. This review concluded the forms of nanopharmaceuticals accessible up to present with the most important health risk relevant information applications & nanoparticles involved. Sovan Lal Pal et. al. (2011) The creation of new drug delivery mechanisms utilising nanoparticles has developed a growing interest in recent years. Nanoparticles may provide major advantages over traditional drug delivery in terms of high durability, high precision, high drug carrying power, managed release flexibility, probability of usage in multiple routes of administration, & the potential to deliver both hydrophilic & hydrophobic drug molecules. This analysis focuses on definition, planning processes, characterisation, utilize, nanoparticles effects & health outlooks. Saba Hasan et. al. (2015) Nanotechnology involves the creation & use of materials whose components occur at the nanoscale; & up to 100 nm in size, by definition. Nanotechnology investigates both electrical, mechanical, and magnetic behaviour and molecular & submolecular structural behaviour. It has the ability to change a range of practices and methodologies in medicine &biotechnology and make them compact, quicker, simpler & cheaper to implement. Nanoparticles are utilized for a variety of aim, from medical treatments to including energy storage batteries in numerous branches of industry, clothing, optical devices, catalytics, bactericidal, electronic, sensor technology, biological labelling & treatment of certain cancers. Nanoparticles have drawn significant interest in latest time, owing to their attractive properties including antibacterial efficacy, good oxidation tolerance and strong thermal conductivity. Nanoparticles may be chemically or biologically synthesised. There are various forms of metal nanoparticles that have enormous uses in industries, including gold , silver, steel, magnetic, respectively.

Nanoparticles have also been used with considerable effectiveness as drug delivery mechanisms. Nanotechnology works on the very thin, & unique in its ability to create systems that could help deliver drugs to specific areas of the body. Often, nano-enabled drug delivery enables drugs to permeate across cell walls, that is crucial to the projected development of genetic medicine over following few years. The reward from nanotechnology-enabled drug distribution to doctors & patients could be reduced medication risk, lower care prices, increased bioavailability & expansion of patented medication economic existence.

Allemann E., Gurny R., Doekler E. (1993). Drug-loaded nanoparticlespreparation methods and drug targeting issues. Eur J Pharm Biopharm.; 39: pp. 173-91. Betancor L. and Luckarift HR. (2008) Trends Biotechnol. 26 566 Dunne M, Corrigan Bodmeier R., Chen H. Indomethacin polymeric nano-suspensions prepared by micro- fluidization. J Control Release. 1990; 12: pp. 223-33. Catarina PR., Ronald JN., Antonio JR (2006). Nano Capsulation. Method of preparation of drug – loaded polymeric nanoparticles: Nano technology, Biology and medicine; 2: pp. 8-21. Chem Phys Lipids (2004)); 132: pp. 3-14. Molpeceres J., Aberturas MR., Guzman M. Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization. J Microencapsul. 2000; 17: pp. 599-614. Cheng Y., Wang J., Rao T., He X., Xu T. (2008). Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery. Front Biosci.; 13: pp. 1447-71. precipitation: effect of the formulation variables on size, drug recovery and release kinetics. J Control release; 83: pp. 389- 400. Couvreur P., Dubernet C., Puisieux F. (1995). Controlled drug delivery with Nano particles:current possibilities and future trends. Eur J Pharm Biopharm.; 41: pp. 2-13. DeAssis DN., Mosqueira VC., Vilela JM., Andrade M.S., Cardoso VN (2008). Release profiles and morphological characterization by atomic force microscopy and photon correlation spectroscopy of 99m Technetium – fluconazole nanocapsules. Int J Pharm.; 349: pp. 152–160. El-Shabouri MH (2002). Positively charged nano particles for improving the oral bioavailability of cyclosporine-A. Int J Pharm.; 249: pp. 101-8. Fessi H., Puisieux F., Devissaguet J-P., Ammoury N., Benita S. (1989). Nano capsule formation by interfacial deposition following solvent displacement. Int J Pharm.; 55: pp. R1-R4. Fu HL., Cheng SX., Zhang XZ., Zhuo RX (2007). Dendrimers/DNA complexes encapsulated in a water soluble polymer and supported on fast degrading star poly (DL-lactide) for localized gene delivery. J Control Release.; 124: pp. 181-8. Goldberg M., Langer R., Jia X. (2007). Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym.; 18: pp. 241-68. Gurny R., Peppas NA., Harrington DD., Banker GS (1981). Development of biodegradable and injectable lattice for control release of potent drugs. Drug Dev Ind Pharm.; 7: pp. 1-25. Hahens WI., Oomen AG., deJong WH., Cassee FR (2007). What do we (need to) know about the kinetic properties of nanoparticles in the body? Regulatory Toxicology and Pharmacology; 49: pp. 217-229. Hett A. (2004). Nanotechnology: small matters, many unknown. Hoet PMH., Brnske HI., Salata OR (2004). Nano particles known and unknown health risk. J nanobiotecnol.; 2: pp. 12. Jaiswal J., Gupta SK., Kreuter J. (2004). Preparation of biodegradable cyclosporine Jani P., Halbert GW., Langridge J., Florence AT (1990). Nanoparticles uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol.; 42(12): pp. 812-826. Jani P., Halbert GW., Langridge J., Florence AT. (1989). The uptake and translocation of latex nanosphere and microsphere after oral administration to rats. J Pharm Pharmacol. 1989; 41(12): pp. 809-812. Jores K., Mehnert W., Drecusler M., Bunyes H., Johan C., MAder K (2004). Investigation on the stricter of solid lipid nanopartuicles and oil-loaded solid nanoparticles by photon correlation spectroscopy, fieldflow fractionasition and transmission electron microscopy. J Control Release; 17: pp. 217- 227. Jung T., Kamm W., Breitenbach A., Kaiserling E., Xiao JK., Kissel T (2000). Biodegradable nano particles for oral delivery of peptides: is there a role for polymer to affect mucosal uptake? Eur J Pharm Biopharm.; 50: pp. 147-60. Lademann J., Weigmann H., Rickmeyer C., Barthelmes H., Schaelmes H., Mueller G., Sterry W. (1999). Penetration of Titanium Dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacology and Applied Skin Physiology; 12: pp. 247- 256. Lambert G., Fattal E., Couvreur P. (2001). Nanoparticulate system for the delivery of antisense oligonucleotides. Adv Drug Deliv Rev.; 47: pp. 99-112. Larson DR., Zipfel WR., Williams RM., Clark SW., Bruchez MP., Wise FW (2003). Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science; 300: pp. 1434-6. Lee KP., Kelly DP., Oneal FO., Kennedy GL (1998). Lung response to ultrafine kertar aramid synthetic fibrils following 2-year inhalation exposure in rats. Findam Appl Toxicol.; 11: pp. 1-20. Lemarchand C., Gref R., Passirani C., Garcion E., Petri B., Muller R. (2006). Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. Biomaterials; 27: pp. 108-18. Discov Technol; 4: pp. 246-54. Magenhein B., Levy MY., Benita S. (1993). A new in vitro technique for the evaluation of drug release profile from colloidal carriersultrafiltration technique at low pressure. Int. J. Pharm.; 94: pp. 115-123. Mecke A., Uppuluri S., Sassanella TM., Lee DK., Ramamoorthy A., Baker Jr JR. Direct observation of lipid bilayer disruption by poly (amidoamine) dendrimers. Muhlen AZ., Muhlen EZ., Niehus H., Mehnert W. (1996). Atomic force microscopy studies of solid lipid nanoparticles. Pharm Res. 13: pp. 1411- 1416. Pangi Z., Beletsi A., Evangelatos K. (2003). PEG-ylated nanoparticles for biological and pharmaceutical application. Adv Drug Del Rev.; 24: pp. 403- 419. Polakovic M., Gorner T., Gref R., Dellacherie E. (1999). Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. J Control Release; 60: pp. 169 -177. Quintanar-Guerrero D., Allemann E., Fessi H., Doelker E. (2001). Preparation techniques and mechanism of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm. 1998; 24:1113-28. Redhead H M., Davis SS. and Illum L. J. Control. Release; 70: pp. 353. Saba Hasan (2015). ―A Review on Nanoparticles: Their Synthesis and Types‖, Research Journal of Recent Sciences International Science Congress Association ISSN 2277-2502 Vol. 4(ISC-2014), 9-11 (2015) Saurabh Bhatia (2016). ―Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications‖, Natural Polymer Drug Delivery Systems, pp. 33-93. Scholes PD., Coombes AG., Illum L., Davis SS., Wats JF., Ustariz C., Vert M., Davies MC (1999). Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. J control Release; 59: pp. 261 - 278. Shi HG., Farber L., Michaels JN., Dickey A., Thompson KC., Shelukar SD., Hurter PN., Reynolds SD., Kaufman MJ (2003). and complementary techniques. Pharm Res. 20: pp. 479 – 484. Song CX., Labhasetwar V., Murphy H., Qu X., Humphrey WR.. Shebuski RJ., Levy RJ (1997). Formulation and characterization of biodegradables nanoparticles for intravascular local drug delivery. J Control Release.; 43: pp. 197- 212. Soppinath KS., Aminabhavi TM., Kulkurni AR., Rudzinski WE (2001). Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release; 70: pp. 1-20. Sovan Lal Pal, Utpal Jana (2011). ―Nanoparticle: An overview of preparation and characterization‖, Journal of Applied Pharmaceutical Science 01 (06); pp. 228-234 ISSN: 2231-3354 Received on: 08-08-2011 Swati Tyagi (2016). ―Nanoparticles – An Overview of Classification and Applications‖, Research & Reviews: Journal of Pharmaceutics and Nanotechnology, e-ISSN: 2347-7857 p-ISSN: 2347-7849. Tabata J., Ikada Y. (1989). Protein pre-coating of polylactide microspheres containing a lipophilic immunopotentiator for enhancement of macrophage phagocytosis and activation. Pharm Res.; 6: pp. 296-301. Takeuchi H., Yamamoto Y (2001). Mucoadhesive nanoparticulate system for peptide drug delivery. Adv Drug Del Rev.; 47: pp. 39-54. Tice TR., Gilley RM (1985). Preparation of injectable controlledrelease microcapsules by solvent- evaporation process. J. Control Release; 2: pp. 343-352. Tomalia DA (2004). Birth of a new macromolecular architecture: Dendrimers as quantized building blocks for nanoscale synthetic organic chemistry. Aldrichimica Acta.; 37(2): pp. 39-57 Tomalia DA (2004). Dendrimer as quantized building blocks for nanoscale synthetic organic chemistry. Aldrichmica Acta.; 37(2): pp. 39-57. Ubrich N., Bouillot P., Pellerin C., Hoffman M., Maincent P. (2004). Preparation and characterization of propanolol hydrochloride nano particles : A comparative study. J Control release: pp. 291-300. lactide) nanoparticles by high pressure emulsification solvent evaporation. J Microencapsul.; 14: pp. 593-605. Vandervoort J., Ludwig A. (2002). Biodegradable stabilizers in the preparation of PLGA nano particles: a factorial design study. Int J Pharm.; 238: pp. 77-92. Vargas A., Pegaz B., Devefve E., Konan- Kouakou Y., Lange N., Ballini JP (2004). Improved photodynamic activity of porphyrin loaded into nano particles: an in vivo evaluation using chick embryos. Int J Pharm.; 286: pp. 131- 45. Wiener EC., Brechbiel MW., Brothers H., Magin RL., Gansow OA.,Tomalia DA (1994). Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med.; 31: pp. 1-8. Yoo HS., Oh JE., Lee KH., Park TG (1999). Biodegradable nano particles containing PLGA conjugates for sustained release. Pharm Res.: 16: pp. 1114-8.

M.Sc. Chemistry, Joint CSIR-UGC Net (June-2017), Joint CSIR-UGC JRF (Dec-2017)